As of May 22
| -0.79 / -0.41%|
The 4 analysts offering 12-month price forecasts for Puma Biotechnology Inc have a median target of 275.50, with a high estimate of 300.00 and a low estimate of 264.00. The median estimate represents a +44.31% increase from the last price of 190.91.
The current consensus among 6 polled investment analysts is to Buy stock in Puma Biotechnology Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.